HighPoint Advisor Group LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
HighPoint Advisor Group LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2022$1,518,000
-16.4%
18,134
-18.3%
0.17%
-6.7%
Q3 2021$1,815,000
-21.9%
22,188
-12.9%
0.18%
-23.9%
Q2 2021$2,324,000
+4.7%
25,472
+0.5%
0.23%
-8.9%
Q1 2021$2,220,000
+1.6%
25,354
+6.2%
0.26%
-3.4%
Q4 2020$2,185,000
+589.3%
23,864
+534.0%
0.27%
+366.7%
Q3 2020$317,000
-9.4%
3,764
-5.6%
0.06%
-24.0%
Q2 2020$350,000
-21.9%
3,986
-20.9%
0.08%
-29.9%
Q1 2020$448,000
-9.9%
5,038
-3.6%
0.11%
+4.9%
Q4 2019$497,000
+15.9%
5,225
+7.6%
0.10%
+7.4%
Q3 2019$429,000
-1.8%
4,856
+4.3%
0.10%
-6.9%
Q2 2019$437,000
+35.7%
4,655
+16.9%
0.10%
+29.1%
Q1 2019$322,000
+0.9%
3,981
+12.2%
0.08%
-6.0%
Q4 2018$319,000
-5.3%
3,547
-8.3%
0.08%
-8.7%
Q3 2018$337,000
+12.7%
3,869
+6.5%
0.09%
+13.6%
Q2 2018$299,000
+14.1%
3,633
+4.5%
0.08%
+12.5%
Q1 2018$262,000
-10.3%
3,4780.0%0.07%
-14.3%
Q4 2017$292,000
+8.1%
3,478
+6.6%
0.08%0.0%
Q3 2017$270,000
+1.9%
3,263
+4.7%
0.08%
-1.2%
Q2 2017$265,0000.0%3,1170.0%0.08%0.0%
Q1 2017$265,000
-22.3%
3,117
-30.8%
0.08%
-22.7%
Q4 2016$341,000
+10.7%
4,506
+6.2%
0.11%
+1.9%
Q3 2016$308,000
+26.2%
4,243
+43.7%
0.11%
+25.6%
Q2 2016$244,000
+60.5%
2,952
+47.8%
0.09%
-7.5%
Q1 2016$152,0001,9970.09%
Other shareholders
NOVARTIS A G shareholders Q4 2017
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders